Toyo Gosei (4970) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The most important point in this earnings report is that the Company posted higher revenue but lower earnings, as it was unable to absorb raw material and manufacturing costs as well as fixed-cost burdens. Revenue was ¥304.1B (+4.6% YoY), Operating Income was ¥20.7B (-32.5%), Ordinary Income was ¥19.9B (-35.9%), and Net Income was ¥13.6B (-35.0%). The increase in revenue was primarily driven by demand for Photosensitivity Materials and other products; however, the gross margin declined to 19.7%, highlighting a structure in which revenue growth is not translating into profit growth.

Factors Affecting Performance

【Revenue】Revenue increased 4.6% YoY to ¥304.1B. By segment, Photosensitivity Materials was the largest segment at ¥188.1B (61.8% of total), but its Operating Income margin remained at only 0.2%. Chemicals generated ¥118.8B in revenue (39.0% of total) and maintained a central role in profitability with a 17.2% profit margin. Low-margin segments account for more than half of total revenue, creating a structure in which top-line growth is unlikely to translate directly into profit growth.

【Profit and Loss】The gross margin declined to 19.7% (from 23.3% based on 6,782/29,073 = 23.3% in the prior year), while the Operating Income margin narrowed to 6.8% (down approximately -3.7pt from 10.6% in the prior year), indicating that the Company has not made sufficient progress in absorbing higher costs and fixed-cost burdens. Ordinary Income was ¥0.8B below Operating Income, with non-operating expenses of ¥2.6B, including ¥2.4B in interest expenses, acting as a drag. Extraordinary losses consisted solely of ¥0.2B in losses on disposal of fixed assets and were not the primary cause of the decline in Net Income. The effective tax rate was 31.1%, and tax expenses were not a particularly significant adverse factor; the main driver of the earnings decline was the deterioration in the Operating Income margin. Revenue increased, but earnings declined.

Segment Analysis

Chemicals generated revenue of ¥118.8B and Operating Income of ¥20.4B, maintaining a high profit margin of 17.2%. In contrast, Photosensitivity Materials accounted for approximately 60% of total revenue at ¥188.1B, but generated only ¥0.3B in Operating Income, resulting in a profit margin of 0.2% and contributing almost nothing to Company-wide profit. Chemicals supports the majority of the Company’s ¥20.7B in Operating Income, making profitability improvement in Photosensitivity Materials the key to recovering the overall profit margin going forward.

Key Financial Indicators

【Profitability】The Operating Income margin of 6.8% and Net Income margin of 4.5% both deteriorated from the prior year, originating from the decline in the gross margin to 19.7%. 【Cash Flow Quality】Annualized DSO was 80 days, DIO was 132 days, and CCC was 147 days, indicating a lengthy working-capital cycle. Accounts receivable of ¥89.0B and inventories of ¥87.8B accounted for 27.2% of total assets. 【Investment Efficiency】ROE was 5.2% and ROIC was 4.3%. The DuPont decomposition, based on total asset turnover of 0.467x and financial leverage of 2.51x, indicates that the low profit margin is the primary cause of the decline in capital efficiency. 【Financial Soundness】The Equity Ratio improved to 39.9% (from 37.7% in the prior year), while the current ratio was 116.1% and the cash/short-term debt ratio was 0.48x. With cash of ¥30.0B against short-term borrowings of ¥63.0B, short-term liquidity is highly dependent on the collection of working capital and the refinancing environment.

Cash Flow Analysis

Because Operating Cash Flow (OCF), investing cash flow, and financing cash flow from the cash flow statement are not included in the disclosed data, fund movements are assessed based on changes in the balance sheet. Cash and deposits remained almost unchanged at ¥30.0B in the current period versus ¥30.0B in the prior year (actually ¥29.96B), while accounts receivable increased from ¥73.7B to ¥89.0B and short-term borrowings increased from ¥46.0B to ¥63.0B. Inventories also increased from ¥84.2B to ¥87.8B, potentially indicating that the tying up of working capital is affecting liquidity. Long-term borrowings declined from ¥170.1B to ¥149.7B, indicating a shift toward a shorter-term interest-bearing debt structure.

Earnings Quality

Against Net Income of ¥13.6B, the only extraordinary loss was a relatively small ¥0.2B loss on disposal of fixed assets. Accordingly, the impact of temporary factors on the earnings decline was limited, with the primary cause being deterioration in recurring operating profitability. Of non-operating income of ¥1.8B, ¥0.5B consisted of foreign exchange gains, which supported Ordinary Income to a certain extent. However, the majority of non-operating expenses of ¥2.6B, or ¥2.4B, consisted of interest expenses, with financial costs reducing Ordinary Income relative to Operating Income. The effective tax rate was 31.1%, within a normal range, and there is no indication that fluctuations in the tax burden materially distorted earnings quality. Overall, the earnings decline can be interpreted as resulting not from temporary items but from the structural factor of a sustained decline in the gross margin.

Earnings Forecast and Guidance

The cumulative Q3 progress rates against the Full-Year forecast were 73.3% for Revenue, 74.0% for Operating Income, and 76.5% for Ordinary Income, generally in line with the standard progress rate of 75%. In contrast, the progress rate for Net Income was relatively low at 67.9%, requiring an additional ¥6.4B to achieve the Full-Year forecast of ¥20.0B. The Full-Year plan calls for Revenue of ¥415.0B (+7.3% YoY) and Operating Income of ¥28.0B (-31.8% YoY), indicating that management has incorporated a significant YoY decline in earnings into its plan. The delay in Net Income progress suggests that attention should be paid to fluctuations in the tax burden and non-operating income and expenses in Q4.

Shareholder Returns

The interim dividend is ¥20 per share, and the Full-Year forecast dividend is ¥40 per share, representing a plan to maintain the prior year’s annual dividend level. Based on cumulative Net Income of ¥13.6B, the cumulative Payout Ratio is 12.0%, while the forecast Payout Ratio against forecast Full-Year Net Income of ¥20.0B is approximately 15.9%; both are low. No disclosure regarding share repurchases was identified, and the assessment is based solely on the dividend Payout Ratio. Although the dividend burden is limited in terms of earnings, the cash sustainability of the dividend may depend on the collection of working capital, given the low cash/short-term debt ratio of 0.48x.

Risk Factors

1. Profitability deterioration risk: The gross margin and Operating Income margin have continued to decline to 19.7% and 6.8%, respectively. Rising raw material prices and delays in passing costs through to selling prices are making it difficult for revenue growth to translate into profit growth.

2. Working capital and liquidity risk: Annualized CCC was 147 days, with accounts receivable of ¥89.0B and inventories of ¥87.8B tying up funds for an extended period. Short-term borrowings of ¥63.0B exceeded cash of ¥29.96B, resulting in a low cash/short-term debt ratio of 0.48x and making short-term liquidity dependent on refinancing and collection conditions.

3. Capital efficiency risk: ROIC of 4.3% and ROE of 5.2% are low relative to the Company’s capital-intensive business structure. Property, plant and equipment of ¥367.4B accounted for 56.4% of total assets, while the decline in the Operating Income margin is pressuring the profitability of invested capital.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s profitability is below the industry median on both metrics, positioning it behind its manufacturing peers in terms of profit margins.

Growth and Capital Efficiency

The Revenue growth rate exceeds the industry median, indicating that top-line expansion is relatively strong.

※Source: Compiled by the Company

Key Takeaways from the Earnings Report

1. Revenue increased 4.6% YoY, but the decline in the gross margin to 19.7% resulted in a 32.5% YoY decrease in Operating Income, indicating weak growth quality. Future earnings improvement will depend on passing higher costs through to selling prices, cost management, and an improved product mix.

2. Accounts receivable and finished-goods inventories accounted for 27.2% of total assets, and annualized CCC reached 147 days. Reducing inventories and accounts receivable, alongside improving profit margins, will be a key focus for improving capital efficiency.

3. While Full-Year progress rates for Revenue, Operating Income, and Ordinary Income were generally around the standard level of 75%, Net Income progress lagged at 67.9%. Trends in the tax burden and non-operating income and expenses in Q4 will be key points to monitor in assessing achievement of the Full-Year plan.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 cumulative performance was weak, with modest sales growth failing to offset a substantial deterioration in manufacturing profitability. Revenue rose 4.6% YoY to ¥30.41bn. Operating income fell 32.5% YoY to ¥2.07bn. Ordinary income declined 35.9% to ¥1.99bn, and net income fell 35.0% to ¥1.36bn. Gross profit decreased 11.7% to ¥5.99bn despite the revenue increase. The gross margin contracted by 365bp YoY to 19.7% from 23.3%. SG&A expenses increased 5.6% to ¥3.91bn, slightly faster than revenue, lifting the SG&A-to-sales ratio by 9bp to 12.9%. Consequently, the operating margin compressed by 374bp to 6.8% from 10.5%. The net margin declined by 272bp to 4.5% from 7.2%. Interest expense increased 61.5% YoY to ¥239m, adding pressure below operating income. FX gains of ¥52m represented only 2.5% of operating income and did not materially alter the earnings picture. The ¥20m loss on disposal of fixed assets was minor, equivalent to 1.5% of net income. Annualized ROE was 7.0%, below the 8% threshold generally associated with adequate capital efficiency. Management's full-year sales forecast implies a fourth-quarter weighting, as Q3 sales progress was 73.3% versus a standard 75.0% pace. Operating-income progress was 74.0%, broadly consistent with the seasonal benchmark, while net-income progress of 67.9% requires a comparatively stronger Q4. The central issue for the outlook is whether gross-margin recovery can offset elevated financing costs and the cash tied up in receivables and inventories.

Profitability Analysis

The annualized DuPont decomposition is net profit margin of 4.5% × asset turnover of 0.622x × financial leverage of 2.51x, producing annualized ROE of 7.0%. The dominant negative driver is margin deterioration: the operating margin fell to 6.8% from 10.5% and the net margin fell to 4.5% from 7.2%. Gross margin compression of 365bp was the principal operational pressure, as cost of sales increased 9.2% YoY against 4.6% revenue growth. SG&A rose 5.6%, exceeding revenue growth and limiting operating leverage; SG&A represented 12.9% of sales, up 9bp YoY. The 19.7% gross margin triggers the low-gross-margin quality alert because it is marginally below the 20% benchmark and materially lower than the prior-year level. In context, 東洋合成 is a capital-intensive chemical manufacturer, where profitability is sensitive to product mix, utilization, raw-material costs, energy costs, and customer pricing; the current cost-sales divergence indicates that these variables require close monitoring. The impact is meaningful because a 374bp operating-margin decline caused operating profit to fall by nearly one-third despite positive sales growth. Financial leverage of 2.51x supports reported ROE but also means returns are partly dependent on debt-funded assets rather than a strong operating return. The five-factor bridge shows a tax burden of 0.689 and an interest burden of 0.951, indicating that the largest pressure sits at the operating-margin level rather than in taxes or interest burden as a percentage of EBIT. Interest coverage remained 8.67x, which is adequate, but the YoY increase in interest expense reduces tolerance for a further margin decline.

Growth Assessment

Revenue growth of 4.6% to ¥30.41bn confirms continued demand expansion at the top line, but profit conversion was weak: gross profit fell 11.7%, operating income fell 32.5%, and net income fell 35.0%. This divergence indicates that the current growth profile is cost-intensive rather than earnings-accretive. Finished goods were ¥8.78bn, while raw materials were ¥2.80bn and work in process was ¥0.20bn, leaving inventory concentrated in finished goods. This composition increases sensitivity to demand timing, product qualification cycles, pricing conditions, and potential inventory valuation pressure in specialty chemical markets. The supplied quality alerts flag DSO of 80 days, DIO of 132 days, and a cash conversion cycle of 147 days; a separate inventory alert flags DIO of 98 days. Each inventory-day alert points to a working-capital burden that is elevated against both the 60-day manufacturing benchmark and the 90-day warning threshold. High receivable days suggest slow cash collection or a sales mix weighted toward customers with longer credit terms; for chemical manufacturers, this can occur with large industrial customers, but it nonetheless increases funding needs. The impact is that sales growth may require disproportionately more balance-sheet capital and may not translate efficiently into cash generation. The full-year forecast calls for revenue of ¥41.50bn, operating income of ¥2.80bn, ordinary income of ¥2.60bn, and net income of ¥2.00bn. Q3 progress is 73.3% for revenue, 74.0% for operating income, 76.5% for ordinary income, and 67.9% for net income, versus the standard 75% Q3 benchmark. None of these progress rates deviates by more than 10 percentage points from the benchmark, but net-income delivery requires a stronger final quarter than the cumulative run rate. The implied full-year operating margin is 6.7%, close to the Q3 cumulative 6.8%, suggesting the forecast does not assume a major margin recovery.

Financial Health

Liquidity is positive but tight. The current ratio was 1.16x, above 1.0x and therefore not indicative of an immediate current-liability coverage deficit, but below the 1.5x level generally viewed as healthy. The quick ratio was 0.74x, showing that current-liability coverage relies materially on inventory conversion. Working capital was ¥3.38bn. Cash and deposits of ¥3.00bn covered only 0.48x of short-term loans, triggering the liquidity-stress alert. The root cause is a short-term loan balance of ¥6.30bn relative to cash, alongside working capital committed to ¥8.90bn of receivables and ¥8.78bn of inventories. In a capital-intensive chemical manufacturing context, some bank borrowing is normal, but the combination of sub-1.0x quick ratio, long working-capital cycle alerts, and low cash-to-short-term-debt coverage limits financial flexibility. The impact is greater reliance on receivable collection, inventory monetization, and refinancing to meet short-term funding needs. Short-term loans increased ¥1.70bn, or 37.0% YoY, to ¥6.30bn. This shift is significant because total interest-bearing debt remained high at ¥21.27bn, comprising ¥6.30bn of short-term loans and ¥14.97bn of long-term loans. Debt-to-equity was 1.51x and debt-to-capital was 45.0%; both are elevated versus conservative benchmarks but below the explicit high-risk D/E threshold of 2.0x and debt-to-capital concern level of 60%. The short-term debt ratio was 29.6%, and current assets exceeded current liabilities by ¥3.38bn, which partly mitigates maturity mismatch risk. Equity increased to ¥25.98bn from ¥24.83bn, lifting the capital adequacy ratio to 39.9% from 37.7%. PPE was ¥36.74bn, or 56.4% of total assets, confirming a capital-intensive asset base that requires consistently adequate utilization and returns. No material segment fixed-asset impairment or goodwill-related matters were reported.

Notable B/S Changes

Short-term loans: +¥1.70bn (+37.0%) to ¥6.30bn - increased short-term funding reliance; this is material given cash-to-short-term-debt coverage of only 0.48x. Construction in progress: +¥0.25bn (+35.3%) to ¥0.94bn - indicates an active investment pipeline within a capital-intensive production base; project execution and future utilization merit monitoring. Accounts receivable: +¥1.53bn (+20.8%) to ¥8.90bn - growth materially exceeded revenue growth of 4.6%, consistent with the high-DSO alert and increased working-capital absorption. Property, plant and equipment: -¥0.96bn (-2.5%) to ¥36.74bn - the asset base remains substantial at 56.4% of total assets, maintaining high fixed-cost and utilization sensitivity.

Cash Flow Quality

Working-capital indicators point to a heightened risk that accounting earnings convert slowly into cash. Accounts receivable increased 20.8% YoY to ¥8.90bn, materially faster than revenue growth of 4.6%. Inventories increased 4.3% to ¥8.78bn and remained concentrated in finished goods. The DSO alert of 80 days is above the 60-day warning level; its root cause is the high receivables balance relative to sales, its industrial-customer context may include negotiated credit terms, and its impact is delayed cash collection and increased funding dependence. The DIO alert of 132 days is well above the 90-day warning level; the root cause is the large finished-goods inventory balance, the context is potentially extended production and customer-delivery cycles in specialty chemicals, and the impact is higher obsolescence, pricing, and carrying-cost exposure. The additional DIO alert of 98 days also exceeds the 60-day manufacturing benchmark, reinforcing that inventory efficiency is a material issue even under an alternative calculation basis. The 147-day cash conversion cycle alert is above the 120-day warning threshold; its root cause is the combined receivable and inventory burden relative to supplier credit, and its impact is a need for greater external financing to sustain operations and investment. Accounts payable were ¥5.81bn, up 2.3% YoY, a slower rate than receivables, which provides limited offset to cash tied up upstream. The 37.0% rise in short-term loans is consistent with pressure to fund working capital. The quality of earnings should therefore be assessed primarily through changes in receivables, finished-goods inventory, short-term borrowing, and the ability to stabilize gross margin.

Dividend Sustainability

The interim dividend was ¥20.00 per share. Based on Q3 cumulative EPS of ¥171.04, the interim dividend represents approximately 11.7% of cumulative earnings per share. The disclosed calculated payout ratio was 12.0%, indicating a conservative dividend burden relative to current cumulative net income. The full-year forecast dividend is ¥40.00 per share against forecast EPS of ¥251.99, implying a forecast dividend payout ratio of approximately 15.9%. This low earnings payout provides a substantial earnings buffer despite the 35.0% YoY decline in Q3 cumulative net income. Retained earnings of ¥22.53bn also provide balance-sheet support for the distribution policy. However, the dividend’s practical resilience depends on controlling working-capital funding needs, given the cash-to-short-term-debt ratio of 0.48x and the long cash-conversion-cycle alert. A stable ¥40.00 annual dividend appears aligned with the stated earnings forecast and modest payout ratio, provided operating margins and working-capital efficiency do not weaken further.

Risk Assessment

Business risks include Margin risk: gross margin fell 365bp YoY to 19.7%, while cost of sales increased 9.2% against 4.6% sales growth. In specialty chemicals, raw-material, energy, product-mix, utilization, and customer-pricing movements can materially affect profitability., Inventory risk: finished goods of ¥8.78bn dominate disclosed inventory components. The supplied DIO alerts of 132 days and 98 days both exceed relevant manufacturing benchmarks, increasing exposure to slower demand, product obsolescence, and inventory valuation pressure., Customer-collection risk: the DSO alert of 80 days exceeds the 60-day warning level. Slow collection can raise financing needs and reduce cash conversion even when reported revenue grows., Chemical manufacturing compliance risk: a large production asset base of ¥36.74bn requires ongoing attention to plant safety, environmental compliance, quality control, and operational continuity..

Financial risks include Liquidity stress alert: cash-to-short-term-debt of 0.48x is below the 0.5x alert threshold. The root cause is ¥3.00bn of cash versus ¥6.30bn of short-term loans; the impact is greater dependence on working-capital realization and bank refinancing., Refinancing and maturity-profile risk: short-term loans rose 37.0% YoY to ¥6.30bn. Although the current ratio is 1.16x, the quick ratio of 0.74x indicates that liquidity is not fully covered by cash and receivables alone., Leverage risk: interest-bearing debt was ¥21.27bn, D/E was 1.51x, and debt/capital was 45.0%. These levels are manageable with 8.67x interest coverage but leave earnings more exposed to rising rates or additional operating-profit pressure., Capital-efficiency alert: annualized ROIC of 4.3% is below 5%. The root cause is low operating profitability relative to a large capital base; for a capital-intensive manufacturer this is a material issue, and the impact is weaker value creation and reduced capacity to self-fund investment..

Key concerns include Highest priority: restoration of gross margin and operating margin, because operating income fell 32.5% despite revenue growth., High priority: conversion of receivables and finished goods into cash, as indicated by the 147-day cash conversion cycle alert., High priority: stabilization of short-term funding, given the 37.0% increase in short-term loans and 0.48x cash-to-short-term-debt ratio., Moderate priority: achievement of the full-year net-income forecast, as Q3 progress of 67.9% trails the standard 75% pace by 7.1 percentage points..

Investment Implications

Key takeaways include Revenue growth remained positive at 4.6%, but profit conversion deteriorated sharply, with operating income and net income down 32.5% and 35.0%, respectively., Gross-margin compression of 365bp to 19.7% is the principal driver of weaker profitability and is more consequential than below-the-line items., Annualized ROE of 7.0% and annualized ROIC of 4.3% indicate sub-threshold capital efficiency despite financial leverage of 2.51x., The balance sheet supports operations but liquidity is constrained by low cash relative to short-term debt and substantial working-capital balances., The forecast implies broadly stable operating margin from the Q3 cumulative level, making execution on cost control and working-capital discipline central..

Metrics to watch include Gross margin and operating margin versus the Q3 levels of 19.7% and 6.8%, Revenue growth relative to cost-of-sales growth, Accounts receivable, DSO, and customer collection trends, Finished-goods inventory, DIO, and inventory valuation risk, Cash-to-short-term-debt coverage and short-term loan balances, Interest expense and interest coverage, Progress toward full-year revenue of ¥41.50bn, operating income of ¥2.80bn, and net income of ¥2.00bn.

Regarding relative positioning, 東洋合成 exhibits the characteristics of a capital-intensive specialty chemical manufacturer: PPE represents 56.4% of assets, and earnings sensitivity to utilization, input costs, product mix, and working-capital management is high. Current profitability is below the stated 8–15% operating-margin benchmark and annualized ROE is below the 8% adequacy threshold. Interest coverage remains solid at 8.67x, but relative financial flexibility is constrained by a 0.74x quick ratio, 0.48x cash-to-short-term-debt coverage, and elevated working-capital-cycle alerts.